Abstract
Abstract Rajeshwari Sridhara, PhD, and Robert Temple, MD, who played lead roles in developing the U.S. Food and Drug Administration's draft guidance on enrichment strategies and adaptive design for clinical trials, talk about tends in trial design for oncology drugs.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have